The latest thoracic oncology news
Today three-year follow-up results from Part 1 of the Phase 3 CheckMate -227 trial have…
The first lung cancer patient to be treated with a new type of immunotherapy involving…
The Food and Drug Administration (FDA) granted accelerated approval to selpercatinib for the following indications:…
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1),…
Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and…
A new expert panel consensus statement published simultaneously today in the journals Radiology: Imaging Cancer, Chest and…
A paper published in Oncotarget has shown that the sensitivity of H1299 and A549 cells to concomitant…
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of…
COPD, chronic obstructive pulmonary disease, is linked to a heightened risk of lung cancer in…
In elective surgery, does the likelihood of treatment success depend on how often the hospital…